[1]Ping W,Fu XN.Research progress on clinical application of circulating tumor cells in lung cancer [J].Chin Lung Cancer,2011,14(6):543-546.[平伟,付向宁.肺癌循环肿瘤细胞临床应用的研究进展[J].中国肺癌杂志,2011,14(6):543-546.]
[2]Chen Y,Li H,Qin Q,et al.Detection of circulating tumor cells in peripheral blood of patients with non-small cell lung cancers and relationship with pathological staging[J].Clinical Milltary Medical J,2014,42(2):192-194.[陈燕,李虎,秦琴,等.非小细胞肺癌患者外周血循环肿瘤细胞的检测及与病理分期关系[J].临床军医杂志,2014,42(2):192-194.]
[3]Afify AM,Tate S,Durbin-Johnson B,et al.Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors [J].Nat Med,2006,12(8):895-904.
[4]Zhou XJ,Li LY,Hao HJ,et al.Prognostic value of peripheral blood circulating tumor cells in patients with advanced lung cancer[J].Cancer Progression,2010,5(8):484-490.[周小昀,李龙芸,郝淮杰,等.外周血循环肿瘤细胞在晚期肺癌患者的预测及预后价值研究[J].癌症进展,2010,5(8):484-490.]
[5]Li J,Jiang B,Wan P,et al.Clinical significance of circulating tumor cells in patients with advanced NSCLC[J].China General Practice,2013,16(27):3202-3204.[李晶,姜北,万鹏,等.晚期非小细胞肺癌患者循环肿瘤细胞检测的临床意义[J].中国全科医学,2013,16(27):3202-3204.
[6]Chen Y,Wang Q.Erlotinib therapy on the immune function of patients with BSCLC effect [J].Digest World Latest Med Inf,2015,15(92):85.[陈业,王琼.厄洛替尼靶向治疗对非小细胞肺癌患者免疫功能与临床疗效的影响[J].世界最新医学信息文摘,2015,15(92):85.]
[7]Han CH,Guo WB,Chen Y,et al.Circulating tumor cells in peripheral blood of the predictive value of elderly patients with small cell lung cancer early metastasis deterioration[J].Chin J Gerontol,2015,35(9):2449-2451.[韩朝辉,郭伟浜,陈钰,等.外周血循环肿瘤细胞预测老年小细胞肺癌患者早期转移恶化的价值[J].中国老年学杂志,2015,35(9):2449-2451.]
[8]Wang B,Tian YP.The expression of AEG-1mRNA in peripheral blood of patients with non-small celllung cancer and its clinical significance[J].Modern Oncology,2014,22(4):823-826.[王冰,田亚平.非小细胞肺癌患者外周血AEG-1mRNA 的表达及临床意义[J].现代肿瘤医学,2014,22(4):823-826.]
[9]Chen P.Advances in detection of circulating tumor cells in NSCLC[J].Clin Oncol in China,2013,40(14):862-865.[陈鹏.非小细胞肺癌循环肿瘤细胞检测进展[J].中国肿瘤临床,2013,40(14):862-865.]
[10]Wan JW,Shen HY,Huang HY,et al.A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer[J].J Clinical and Pathological Research,2015,35(1):43-47.[万佳蔚,沈洪远,黄红宇,等.非小细胞肺癌患者外周血循环肿瘤细胞与临床特征关系的初步研究[J].临床与病理杂志,2015,35(1):43-47.]
[11]Wang YH,Wang LR,Sun W,et al.Peripheral blood circulating tumor cells in patients with advanced non small cell lung cancer:a report of 5 cases and literature review[J].China Medical Guide,2014,12(22):269-270.[王英慧,王丽茹,孙巍,等.晚期非小细胞肺癌患者外周血循环肿瘤细胞检测5例并文献复习[J].中国医药指南,2014,12(22):269-270.]
[12]Du KQ,Zhu YC,Yang Y,et al.Significance of detecting circulating tumor cells in peripheral blood of postoperative patients with non -small cell lung cancer[J].Med J Chin PAPF,2013,24(9):786-788.[杜开齐,朱有才,杨勇,等.非小细胞肺癌术后外周血循环肿瘤细胞的检测及其意义[J].武警医学,2013,24(9):786-788.]
[13]Liu CH,Yang Z,Li N,et al.The relationship between circulating tumor cells and clinieopathologic characteristics of primary lung cancer patients[J].Chongqing Medicine,2014,43(20):2565-2567.[刘春花,杨政,李娜,等.循环肿瘤细胞与肺癌临床病理特征的关系[J].重庆医学,2014,43(20):2565-2567.]
[14]Wang HP,Zhang L.Prediction of circulating tumor cells in patients with NSCLC[J].Cancer Progression,2015,13(4):369-375.[王汉萍,张力.非小细胞肺癌患者中循环肿瘤细胞的预测作用[J].癌症进展,2015,13(4):369-375.]
[15]Liang JG,Gao XD,Jin ZY,et al.Clinical study on circulating tumor cell counts of non small cell lung cancer [J].J Inner Mongolia Medical University,2013,35(S2):310-314.[梁俊国,高旭东,靳智勇,等.非小细胞肺癌的循环肿瘤细胞计数的临床研究[J].内蒙古医科大学学报,2013,35(S2):310-314.]